Clal Biotechnology reported ILS-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2022.





Eps Change Date
Arca Biopharma USD -0.58 0.04 Mar/2026
aTyr Pharma USD -0.06 0.59 Mar/2026
Bio Path USD -0.04 0.04 Mar/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
Immunic USD -0.1 0.03 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
RedHill Biopharma USD -1.31 33.38 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024